Effect of Early L-Carnitine Supplementation on Neurodevelopmental Outcomes in Very Preterm Infants

NCT01783041 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

144

Enrollment

OTHER

Sponsor class

Conditions

Prematurity
Neurodevelopmental Disorder
Carnitine Deficiency

Interventions

DRUG: L-carnitine
DRUG: 5% Dextrose

Sponsor

Montefiore Medical Center

Collaborators

[object Object]